If you have been reading about GLP-1 receptor and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
The compound binds the GLP-1 receptor on pancreatic beta cells and other tissues, activating a G-protein signaling cascade that raises intracellular cyclic AMP. This action increases glucose-dependent insulin secretion when blood glucose is elevated, while binding also slows gastric emptying and reduces glucagon release. In the central nervous system, receptor activation in the hypothalamus and brainstem contributes to reduced appetite. The fatty acid chain binds albumin, which protects the peptide from renal filtration and enzymatic degradation. This albumin binding is central to its extended circulation time.
Native GLP-1 is degraded rapidly by dipeptidyl peptidase-4. Semaglutide resists this cleavage because alanine at position 8 is replaced by alpha-aminoisobutyric acid. A second substitution at position 34 introduces arginine, which further stabilizes the peptide. The most distinctive modification is a spacer and C18 fatty diacid attached at lysine 26, enabling strong albumin affinity. These three changes together produce a half-life measured in days rather than minutes, and the same structural logic underlies other long-acting analogs in this class.
Clinical development of this compound followed earlier short-acting GLP-1 analogues that required frequent injection. Once-weekly subcutaneous formulations entered use after 2017, and an oral formulation using a permeation enhancer later became available. The oral version pairs the peptide with sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, a carrier that improves uptake across the gastric epithelium. Interest has expanded from glycaemic control into weight management and metabolic liver disease. Regulatory status and approved indications differ between countries, and the product remains subject to ongoing safety monitoring.
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | 31 amino acids |
| Backbone modification | Aib at position 8 | Blocks DPP-4 cleavage |
| Fatty acid chain | C18 diacid | Supports albumin binding |
| Native half-life | 1 to 2 minutes | Endogenous GLP-1 |
| Analog half-life | Approximately one week | Extended by albumin binding |
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities by hydrophobicity. Mass spectrometry confirms molecular weight and detects truncation or modification products. Peptide mapping after enzymatic digestion verifies the amino acid sequence. Quantitation is often performed by LC-MS/MS or by immunoassay, and the two approaches can give different values because they measure different things. Method validation parameters such as accuracy, precision, and limit of quantitation are reported alongside results.
Certificate of analysis documents from suppliers typically report purity by chromatographic area, water content, and counter-ion identity. Independent verification is advisable because reported values can be generated under differing conditions. Impurity profiles matter for research use, where aggregates, deamidation products, and residual solvents may influence experimental results. Container, lot, and chain-of-custody records support traceability. Analytical results are method-dependent, so comparisons between laboratories require the same procedure and reference standards.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
The third season of the American satirical superhero television series The Boys, the first series in the franchise based on the comic book series of the same name written by Garth Ennis and Darick Robertson, was developed for television by American writer and television producer Eric Kripke. The season is produced by Sony Pictures Television Studios and Amazon Studios in association with Point Grey Pictures, Original Film, Kripke Enterprises, Kickstart Entertainment and KFL Nightsky Productions. The show's third season stars Karl Urban, Jack Quaid, Antony Starr, Erin Moriarty, Dominique McElligott, Jessie T. Usher, Laz Alonso, Chace Crawford, Tomer Capone, Karen Fukuhara, Nathan Mitchell, Colby Minifie, and Claudia Doumit returning from prior seasons, with Jensen Ackles joining the cast. Taking place a year after the events of the previous season, the season follows the titular Boys now working for Victoria Neuman's Bureau of Superhero Affairs to apprehend problematic Supes, having been at peace with the Seven. However, the conflict is resurrected once Butcher, Hughie & the rest of the Boys reunite to investigate the truth about the apparent death of Soldier Boy, one of Vought's first American superheroes, with the hopes of killing Homelander for good. Concurrently, Homelander's mental stability begins to deteriorate as Vought attempts to restrict his power while other Seven members, such as Annie January/Starlight and Queen Maeve, assist the Boys in their plots against him.
=== Sources of toxicity === Diet – Liver is high in vitamin A. The liver of certain animals, including the polar bear, bearded seal, fish and walrus, are particularly toxic (see Liver (food) § Poisoning). It has been estimated that consumption of 500 grams (18 oz) of polar bear liver would result in an acute toxic dose for humans. Supplements – Dietary supplements can be toxic when taken above recommended dosages. Cod liver oil - According to the United States Department of Agriculture, a tablespoon (13.6 grams or 14.8 mL) of cod liver oil contains 4,080 μg of vitamin A. The tolerable upper intake level (UL) is 3000 μg/day for adults, 600 μg/day for children ages 1–3 years and 900 μg/day for children ages 4–8 years, so for all ages, but especially for young children, a tablespoon a day exceeds the UL.
== NFL career == The Washington Redskins signed him on August 15, 2015. This came on the back of Niles Paul and Logan Paulson being placed on the Injured Reserve list. He was waived on August 31, 2015.
April 13, 1978: Creation of the State Secretariat for Women's Employment, attached to the Ministry of Labor and Participation; assigned to Nicole Pasquier. July 12, 1978: Law with various measures in favor of maternity. July 26, 1978: Decree amending Decree 68-92 of January 29, 1968, on the special status of police officers and peacekeepers of the national police; women may apply. September 11, 1978: Creation of the Ministry Delegate for Women's Status, replacing the delegation for women's status; assigned to Monique Pelletier. January 2, 1979: Law on working hours and night work for women. December 31, 1979: Law on voluntary termination of pregnancy, completing the January 1975 law. July 17, 1980: Law with various provisions to improve the situation of large families. December 23, 1980: Law on the punishment of rape and certain sexual offenses; rape is defined as: "Any act of sexual penetration, of any kind, committed on another person by violence, coercion, threat, or surprise, is rape"; it becomes a crime. September 30, 1981: Decree on the responsibilities of the Minister Delegate to the Prime Minister, Minister for Women's Rights, Mme Yvette Roudy. October 12, 1981: Publication of three decrees: abortion reimbursed at 75%, residency requirement shortened for foreign women, all public healthcare institutions required to have an abortion center; and a national contraception awareness campaign launched by Minister Yvette Roudy. January 20, 1982: March 8 becomes Women's Day in France, on the proposal of Yvette Roudy and accepted by the Council of Ministers.
=== 1. Gingiva === The gingiva is the visible soft-tissue component of the periodontium and forms a biological seal around the cervical region of the teeth, protecting the underlying periodontal structures from mechanical trauma and microbial invasion.
Sources: en.wikipedia.org
Plasma is normally yellow due to bilirubin, carotenoids, hemoglobin, and transferrin. In abnormal cases, plasma can have varying shades of orange, green, or brown. The green color can be due to ceruloplasmin or sulfhemoglobin. The latter may form due to medicines that are able to form sulfonamides once ingested. A dark brown or reddish color can appear due to hemolysis, in which methemoglobin is released from broken blood cells. Plasma is normally relatively transparent, but sometimes it can be opaque. Opaqueness is typically due to elevated content of lipids like cholesterol and triglycerides.
=== Brain nonsynaptic glutamatergic signaling circuits === Extracellular glutamate in Drosophila brains has been found to regulate postsynaptic glutamate receptor clustering, via a process involving receptor desensitization. A gene expressed in glial cells actively transports glutamate into the extracellular space, while, in the nucleus accumbens-stimulating group II metabotropic glutamate receptors, this gene was found to reduce extracellular glutamate levels. This raises the possibility that this extracellular glutamate plays an "endocrine-like" role as part of a larger homeostatic system.
=== Discoveries in chemistry === By the 18th century the principle of conservation of mass during chemical reactions was widely used and was an important assumption during experiments, even before a definition was widely established, though an expression of the law can be dated back to Hero of Alexandria's time, as can be seen in the works of Joseph Black, Henry Cavendish, and Jean Rey. One of the first to outline the principle was Mikhail Lomonosov in 1756. He may have demonstrated it by experiments and certainly had discussed the principle in 1748 in correspondence with Leonhard Euler, though his claim on the subject is sometimes challenged. According to the Soviet physicist Yakov Dorfman:The universal law was formulated by Lomonosov on the basis of general philosophical materialistic considerations, it was never questioned or tested by him, but on the contrary, served him as a solid starting position in all research throughout his life. A more refined series of experiments were later carried out by Antoine Lavoisier who expressed his conclusion in 1773 and popularized the principle of conservation of mass. The demonstrations of the principle disproved the then popular phlogiston theory that said that mass could be gained or lost in combustion and heat processes. The conservation of mass was obscure for millennia because of the buoyancy effect of the Earth's atmosphere on the weight of gases. For example, a piece of wood weighs less after burning; this seemed to suggest that some of its mass disappears, or is transformed or lost.
==== Environmental effects ==== The way in which new structures mature as they are produced may be affected by the point in the plant's life when they begin to develop, as well as by the environment to which the structures are exposed. This can be seen in aquatic plants.
Sources: en.wikipedia.org
It is a synthetic analog of GLP-1 produced through medicinal chemistry to resist enzymatic degradation. The design goal was longer circulation than the native hormone.
A fatty acid side chain attaches the peptide to serum albumin, which shields it from kidney filtration and protease activity. This interaction is the main reason its circulation time is extended.
No. The native hormone is GLP-1, and semaglutide is an engineered variant with three deliberate structural alterations. It does not appear in unmodified biological sources.
It belongs to the incretin mimetic class and acts as a long-acting glucagon-like peptide-1 receptor agonist. The class includes several peptides with different half-lives and routes of administration.